Periprothetische Infektionen – operatives und medikamentöses Management

Periprothetische Infektionen (PPI) stellen eine große Herausforderung dar. Die Therapie einer PPI bedeutet für Betroffene häufig eine deutlich verminderte Gelenkfunktion und Einschränkung der Lebensqualität. Entscheidend für einen Behandlungserfolg nach PPI ist ein strukturierter Behandlungsalgorithmus mit sowohl chirurgischer als auch antibiotischer Therapie. Dieser Beitrag vermittelt aktuelle Aspekte des Managements von Endoprotheseninfektionen.

Schlüsselwörter

Endoprotheseninfektion - Prothesenwechsel - Biofilm - Antibiotika - Infektionsprophylaxe

• Literatur

• 1 Premkumar A, Kolin DA, Farley KX. et al. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty 2021; 36: 1484-1489.e3
• 2 Koh CK, Zeng I, Ravi S. et al. periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: an analysis of 11,134 knees. Clin Orthop Relat Res 2017; 475: 2194-2201
• 3 Patel R. Periprosthetic joint infection. N Engl J Med 2023; 388: 251-262
• 4 Zmistowski B, Karam JA, Durinka JB. et al. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am 2013; 95: 2177-2184
• 5 Rottier W, Seidelman J, Wouthuyzen-Bakker M. Antimicrobial treatment of patients with a periprosthetic joint infection: basic principles. Arthroplasty 2023; 5: 10
• 6 Garrigues GE, Zmistowski B, Cooper AM. et al. Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: evaluation of periprosthetic shoulder infection. J Shoulder Elbow Surg 2019; 28: S32-S66
• 7 Hubert J, Ries C, Dalos D. et al. Prävention und Diagnostik von periprothetischen Infektionen. Orthop Unfallchir up2date 2021; 16: 291-310
• 8 Sigmund IK, Luger M, Windhager R. et al. Diagnosing periprosthetic joint infections: a comparison of infection definitions: EBJIS 2021, ICM 2018, and IDSA 2013. Bone Joint Res 2022; 11: 608-618
• 9 McNally M, Sousa R, Wouthuyzen-Bakker M. et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J 2021; 103-B: 18-25
• 10 Peel TN, Astbury S, Cheng AC. et al. Multicentre randomized double-blind placebo-controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis in arthroplasty surgery. Orthop Procs 2023; 105-B (Suppl. 12) 21
• 11 Hornuß D, Rieg S. Antibiotikaallergien – gezieltes Vorgehen bei vermeintlicher β-Laktam-Allergie. Inn Med 2023; 64: 351-361
• 12 Osmon DR, Berbari EF, Berendt AR. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: e1-e25
• 13 Zimmerli W, Sendi P. Role of rifampin against staphylococcal biofilm infections in vitro, in animal models, and in orthopedic-device-related infections. Antimicrob Agents Chemother 2019; 63: e01746–18
• 14 Esposito S, Leone S, Bassetti M. et al. Bone Joint Infections Committee for the Italian Society of Infectious Tropical Diseases (SIMIT). Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection 2009; 37: 478-496
• 15 Benkabouche M, Racloz G, Spechbach H. et al. Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial. J Antimicrob Chemother 2019; 74: 2394-2399
• 16 Bernard L, Arvieux C, Brunschweiler B. et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med 2021; 384: 1991-2001
• 17 Lora-Tamayo J, Euba G, Cobo J. et al. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial. Int J Antimicrob Agents 2016; 48: 310-316
• 18 Terhalle E, Jung N, Stegemann MS. et al. Neue Entwicklungen in der ambulanten parenteralen Antibiotikatherapie (APAT). Dtsch Med Wochenschr 2020; 145: 1688-1694
• 19 Kunutsor SK, Beswick AD, Whitehouse MR. et al. Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes. J Infect 2018; 77: 479-488
• 20 Campbell ST, Goodnough LH, Bennett CG. et al. Antiseptics commonly used in total joint arthroplasty interact and may form toxic products. J Arthroplasty 2018; 33: 844-846
• 21 Gramlich Y, Walter G, Klug A. et al. Procedure for single-stage implant retention for chronic periprosthetic infection using topical degradable calcium-based antibiotics. Int Orthop 2019; 43: 1559-1566
• 22 Roitzsch C, Apolle R, Jan Baldus C. et al. Ultrasonic bone cement removal efficiency in total joint arthroplasty revision: a computer tomographic-based cadaver study. J Orthop Res 2023; 41: 1365-1375
• 23 Pro-Implant Foundation. Pocket Guide zur Diagnostik und Behandlung von periprothetischen Infektionen (Version 11, November 2023). Accessed January 24, 2024 at: www.pro-implant.org
• 24 Hipfl C, Carganico T, Leopold V. et al. Two-stage revision total hip arthroplasty without spacer placement: a viable option to manage infection in patients with severe bone loss or abductor deficiency. J Arthroplasty 2021; 36: 2575-2585
• 25 Paprosky WG, Perona PG, Lawrence JM. Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation. J Arthroplasty 1994; 9: 33-44
• 26 Della Valle CJ, Paprosky WG. The femur in revision total hip arthroplasty evaluation and classification. Clin Orthop Relat Res 2004; (420) 55-62
• 27 Engh GA, Parks NL. The management of bone defects in revision total knee arthroplasty. Instr Course Lect 1997; 46: 227-236
• 28 Stiehler M, Günther KP, Goronzy J. Strategien für die Pfannenrevision. Orthopadie 2023; 52: 12-20
• 29 Wildeman P, Rolfson O, Söderquist B. et al. What are the long-term outcomes of mortality, quality of life, and hip function after prosthetic joint infection of the hip? A 10-year follow-up from Sweden. Clin Orthop Relat Res 2021; 479: 2203-2213
• 30 Lazic I, Scheele C, Pohlig F. et al. Treatment options in PJI – is two-stage still gold standard?. J Orthop 2021; 23: 180-184
• 31 Kurtz SM, Higgs GB, Lau E. et al. Hospital costs for unsuccessful two-stage revisions for periprosthetic joint infection. J Arthroplasty 2022; 37: 205-212
• 32 Kim K, Zhu M, Cavadino A. et al. Failed debridement and implant retention does not compromise the success of subsequent staged revision in infected total knee arthroplasty. J Arthroplasty 2019; 34: 1214-1220.e1
• 33 Uriarte I, Moreta J, Mosquera J. et al. Debridement, antibiotics and implant retention for early periprosthetic infections of the hip: outcomes and influencing factors. Hip Pelvis 2019; 31: 158-165
• 34 de Vries LMA, Neve WC. et al. Prosthesis retention after an infected hip prosthesis: hip fractures versus primary total hip prosthesis, data from 1998–2015. J Bone Jt Infect 2018; 3: 118-122